short stride length_Tg(Prnp-ATXN3*148Q)148.19Olri/0

http://metadb.riken.jp/0001407IC57BL6NTgPrnpATXN3148Q14819Olri0TgPrnpATXN3148Q14819Olri

short stride length_Tg(Prnp-ATXN3*148Q)148.19Olri/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 148.19, Olaf Riess
  http://metadb.riken.jp/db/mgi_rdf/MGI:5516450

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Prnp-ATXN3*148Q)148.19Olri/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Prnp-ATXN3*148Q)148.19Olri

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: C57BL/6N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• short stride length
  http://purl.obolibrary.org/obo/MP_0001407

文献

http://purl.org/net/cito/citesAsAuthority

• Ulrike. Bichelmeier, et.al., Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence., The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, 27
  http://rdf.ncbi.nlm.nih.gov/pubmed/17626202